CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 122 enrolled
Drug / intervention
phenolization +1 moredrug
Likely dose
phenolization 18 Gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05404243
NCT05404243Phase 4Completed
CompareCT.gov

Randomized Clinical Trial to Test the Efficacy and Safety of Phenolization in Uncomplicated Sacrococcygeal Pilonidal Disease

HJ23·interventional·Posted Jun 3, 2022·Updated Jun 7, 2022

In Brief

A Phase 4 clinical trial evaluating phenolization and Conventional surgery for Sacrococcygeal Fistula and 3 related conditions. Completed, enrolled 122 participants across 1 site.

Detailed Summary

Randomized clinical trial to test the efficacy and safety of phenolization in uncomplicated Sacrococcygeal pilonidal disease

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSacrococcygeal Fistula, Pilonidal Sinus, Pilonidal Disease, Pilonidal Disease of Natal Cleft
CountriesSpain
Collaborators--

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedJun 3, 2022
Enrollment StartJan 1, 2021
Primary CompletionDec 1, 2021
Study CompletionMay 1, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.1 years ago

Interventions

phenolizationdrug

In case of phenolization group, an Abbocath catheter 18 G is introduced into the cystic cavity. Undiluted 88% phenol is instilled into the cavity, ensuring that the cystic cavity is filled. It is maintained for 5 min until complete coagulation of the cyst is achieved.

Conventional surgeryprocedure

In case of conventional surgery, entire exeresis is performed by means of an electric scalpel